Removal of cell-bound lipoproteins: A crucial step for the efficient infection of liver cells with hepatitis C virus in vitro

Comptes Rendus de l'Academie des Sciences-Serie III

Volumn 324, Issue 12, 2001, Pages 1141-1148

  Favre, Daniel ^a   Berthillon, Pascale ^a   Trépo, Christian ^a  

^a INSERM   (France)

Author keywords

Cancer; Disease; HCV; Hepatitis C virus; Hepatocellular carcinoma; Hepatocyte; In vitro; Infection; Lipoproteins

Indexed keywords

CELL RECEPTOR; LIPOPROTEIN;

VIRAL DISEASE;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; LIVER CELL; PROTEIN BINDING; SERUM; VIRUS INFECTION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; PAN TROGLODYTES;

EID: 0035664883     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(01)01397-X     Document Type: Article

References (62)

1. Viral hepatitis
2. Viral hepatitis: Current status and issues
3. Biology of Human Hepatitis Viruses
4. Diagnosis, therapy, and prognosis of viral hepatitis
5. More than third of world's population has been infected with hepatitis B virus
6. Hepatitis C virus infection
7. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
8. Chronic hepatitis
9. Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe
10. Viruses and cancer: Possible role of hepatitis C virus
11. Hepatitis C virus and hepatocarcinogenesis
12. The global health burden of infection associated cancers
13. Hepatitis B virus and liver cancer: Unanswered questions
14. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
15. Cell-based animal models for hepatitis B and C viruses
16. Replication of hepatitis C virus
17. The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection
18. Transfection of HepG2 cells with infectious hepatitis C virus genome
19. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells
20. HCV cDNA transfection to HepG2 cells
21. Replication and multiplication of hepatitis C virus genome in human foetal liver cells
22. Systems to culture hepatitis C virus
23. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using standard strand-specific RT/PCR
24. Establishment of persistent hepatitis C virus infection and replication in vitro
25. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line
26. Infection of human hepatocyte cell lines with hepatitis C virus in vitro
27. Transfection of a differentiated human hepatoma cell line (HuH7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV
28. Infection of peripheral mononuclear blood cells by hepatitis C virus
29. Characterization of hepatitis C virus F2 glycoprotein interaction with a putative cellular receptor, CD81
30. Binding of hepatitis C virus to CD81
31. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
32. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
33. Lipoprotein metabolism
34. Iroglitazone upregulates LDL receptor activity in HepG2 cells
35. Lipoprotein metabolism
36. First cysteine-rich repeat in ligand-binding domain of low density lipoprotein receptor binds Ca++ and monoclonal antibodies, but not lipoproteins
37. The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line HepG2
38. The binding of human lipoprotein lipase treated VEDI by the human hepatoma cell line HepG2
39. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
40. Association of hepatitis C virus in human sera with beta-lipoprotein
41. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins
42. Conservation of the conformation and positive charges of hepatitis C virus F2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment
43. Receptor-mediated entry of hepatitis B virus particles into liver cells
44. Hepatitis B virus surface antigen binds to apolipoprotein H
45. Receptor-mediated endocytosis
46. Receptor-mediated endocytosis: Mechanisms, biologic function, and molecular properties
47. Sur le dosage rapide du cholesterol lié aux alpha et aux beta-lipoprotéines du sérum
48. A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques
49. Cholesterol in high-density lipoprotein: Use of Mg2+/dextran sulfate in its enzymic measurement
50. Dextran sulfate Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
51. Beta-lipoproteins influence the serum level of hepatitis C virus
52. Report of a fatal case of Dengue infection with hepatitis: Demonstration of Dengue antigens in hepatocytes and liver apoptosis
53. Three different patterns of hepatitis C virus infection in chimpanzees
54. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: Comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia
55. In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus
56. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
57. Internal ribosome entry site within hepatitis C virus RNA
58. Mechanism of translation initiation on hepatitis C virus RNA
59. Mammalian cell culture: Essential techniques
60. Internal ribosome entry site-mediated translation of a mammalian mRNA is regulated by amino acid availability